Loading...

David Daikh, MD

TitleProfessor
SchoolUCSF School of Medicine
DepartmentMedicine
Address4150 Clement St
San Francisco CA 94121
Phone415-750-2104
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San Francisco Residency Internal Medicine

    Collapse Overview 
    Collapse Overview
    Dr. Daikh is the Rheumatology Division Chief at the SFVA Medical Center, and director of the rheumatology fellowship program at UCSF. Dr. Daikh’s research focuses on immune mechanisms of rheumatic disease, and he directs a core laboratory that serves a number of investigators at UCSF. Dr. Daikh is also the President of the Rheumatology Research Foundation.


    Collapse Research 
    Collapse Research Activities and Funding
    A Controlled Trial of CBT for Multiple Sclerosis Inflammation
    NIH/NICHD R01HD043323Sep 1, 2003 - Jun 30, 2011
    Role: Principal Investigator
    T CELL COST IMMULATION ON MURINE LUPUS
    NIH/NIAID K08AI001520Sep 1, 1997 - Aug 31, 2003
    Role: Principal Investigator
    Academic Rheumatology and Clinical Immunology
    NIH/NIAMS T32AR007304Jul 1, 1978 - Apr 30, 2019
    Role: Principal Investigator
    MULTIPURPOSE ARTHRITIS AND MUSCULOSKELETAL DISEASES CTR
    NIH/NIAMS P60AR020684Sep 15, 1977 - Dec 31, 2003
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Websites
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Andrews JS, Trupin L, Hough CL, Daikh D, Yelin EH, Katz PP. Serum biomarkers of inflammation and muscle strength among women with systemic lupus erythematosus. Cytokine. 2016 Nov 15; 90:109-112. PMID: 27863333.
      View in: PubMed
    2. Bays A, Wahl E, Daikh D, Yazdany J, Schmajuk G. Implementation of disease activity measurement for rheumatoid arthritis patients in an academic rheumatology clinic. BMC Health Serv Res. 2016; 16(a):384. PMID: 27527720.
      View in: PubMed
    3. Daikh D, Chen PP. Advances in managing ankylosing spondylitis. F1000Prime Rep. 2014; 6:78. PMID: 25343035; PMCID: PMC4166936.
    4. Schmajuk G, Miao Y, Yazdany J, Boscardin WJ, Daikh D, Steinman MA. Identification of risk factors for elevated transaminases in methotrexate users through an electronic health record. Arthritis Care Res (Hoboken). 2014 Aug; 66(8):1159-66. PMID: 24470205; PMCID: PMC4112168.
    5. Yazdany J, Schmajuk G, Robbins M, Daikh D, Beall A, Yelin E, Barton J, Carlson A, Margaretten M, Zell J, Gensler LS, Kelly V, Saag K, King C. Choosing wisely: the American College of Rheumatology's Top 5 list of things physicians and patients should question. Arthritis Care Res (Hoboken). 2013 Mar; 65(3):329-39. PMID: 23436818; PMCID: PMC4106486.
    6. Mohr DC, Lovera J, Brown T, Cohen B, Neylan T, Henry R, Siddique J, Jin L, Daikh D, Pelletier D. A randomized trial of stress management for the prevention of new brain lesions in MS. Neurology. 2012 Jul 31; 79(5):412-9. PMID: 22786596; PMCID: PMC3405245.
    7. Hahn BH, McMahon MA, Wilkinson A, Wallace WD, Daikh D, Fitzgerald JD, Karpouzas GA, Merrill JT, Wallace DJ, Yazdany J, Ramsey-Goldman R, Singh K, Khalighi M, Choi SI, Gogia M, Kafaja S, Kamgar M, Lau C, Martin WJ, Parikh S, Peng J, Rastogi A, Chen W, Grossman JM. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken). 2012 Jun; 64(6):797-808. PMID: 22556106; PMCID: PMC3437757.
    8. Daikh D, St Clair EW. Updated recommendations for the treatment of rheumatoid arthritis: another step on a long road. Arthritis Care Res (Hoboken). 2012 May; 64(5):648-51. PMID: 22473919; PMCID: PMC4097090.
    9. Ashouri JF, Daikh D. Rheumatic manifestations of cancer. Rheum Dis Clin North Am. 2011 Nov; 37(4):489-505. PMID: 22075194.
      View in: PubMed
    10. Charles JF, Eberle C, Daikh D, Rooney T. Resolution of recurrent fusarium arthritis after prolonged antifungal therapy. J Clin Rheumatol. 2011 Jan; 17(1):44-5. PMID: 21169847.
      View in: PubMed
    11. Scalapino KJ, Daikh D. Suppression of glomerulonephritis in NZB/NZW lupus prone mice by adoptive transfer of ex vivo expanded regulatory T cells. PLoS One. 2009; 4(6):e6031. PMID: 19551149; PMCID: PMC2696596.
    12. Gupta VA, Hermiston ML, Cassafer G, Daikh D, Weiss A. B cells drive lymphocyte activation and expansion in mice with the CD45 wedge mutation and Fas deficiency. J Exp Med. 2008 Nov 24; 205(12):2755-61. PMID: 19001138; PMCID: PMC2585841.
    13. Scalapino KJ, Daikh D. CTLA-4: a key regulatory point in the control of autoimmune disease. Immunol Rev. 2008 Jun; 223:143-55. PMID: 18613834.
      View in: PubMed
    14. Bahjat FR, Pine PR, Reitsma A, Cassafer G, Baluom M, Grillo S, Chang B, Zhao FF, Payan DG, Grossbard EB, Daikh D. An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus. Arthritis Rheum. 2008 May; 58(5):1433-44. PMID: 18438845.
      View in: PubMed
    15. Kinder BW, Collard HR, Koth L, Daikh D, Wolters PJ, Elicker B, Jones KD, King TE. Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med. 2007 Oct 1; 176(7):691-7. PMID: 17556720; PMCID: PMC1994238.
    16. Buxbaum J, Qian P, Khuu C, Shneider BL, Daikh D, Gershwin ME, Allen PM, Peters MG. Novel model of antigen-specific induction of bile duct injury. Gastroenterology. 2006 Dec; 131(6):1899-906. PMID: 17087941; PMCID: PMC4113411.
    17. Scalapino KJ, Tang Q, Bluestone JA, Bonyhadi ML, Daikh D. Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells. J Immunol. 2006 Aug 1; 177(3):1451-9. PMID: 16849451.
      View in: PubMed
    18. Daikh D, Gillis J, Wofsy D. Inhibition of T cell costimulation: an emerging therapeutic strategy for autoimmune rheumatic diseases. Arthritis Rheum. 2006 Apr 15; 55(2):322-4. PMID: 16583382.
      View in: PubMed
    19. Daikh D. The Vioxx debacle revisited. Am J Med. 2005 Sep; 118(9):1057. PMID: 16164908.
      View in: PubMed
    20. Davidson A, Diamond B, Wofsy D, Daikh D. Block and tackle: CTLA4Ig takes on lupus. Lupus. 2005; 14(3):197-203. PMID: 15807196.
      View in: PubMed
    21. Cunnane G, Chan OT, Cassafer G, Brindis S, Kaufman E, Yen TS, Daikh D. Prevention of renal damage in murine lupus nephritis by CTLA-4Ig and cyclophosphamide. Arthritis Rheum. 2004 May; 50(5):1539-48. PMID: 15146424.
      View in: PubMed
    22. Cunnane G, Warnock M, Fye KH, Daikh D. Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis. Arthritis Rheum. 2002 Aug; 47(4):445-9. PMID: 12209493.
      View in: PubMed
    23. Schumacher HR, Boice JA, Daikh D, Mukhopadhyay S, Malmstrom K, Ng J, Tate GA, Molina J. Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis. BMJ. 2002 Jun 22; 324(7352):1488-92. PMID: 12077033; PMCID: PMC116444.
    24. Wofsy D, Daikh D. Treatment of autoimmune diseases by inhibition of T-cell costimulation. Mod Rheumatol. 2002 Mar; 12(1):1-4. PMID: 24383824.
      View in: PubMed
    25. Daikh D, Wofsy D. Cutting edge: reversal of murine lupus nephritis with CTLA4Ig and cyclophosphamide. J Immunol. 2001 Mar 1; 166(5):2913-6. PMID: 11207238.
      View in: PubMed
    26. Daikh D, Wofsy D. Treatment of autoimmunity by inhibition of T cell costimulation. Adv Exp Med Biol. 2001; 490:113-7. PMID: 11505969.
      View in: PubMed
    27. Majeti R, Xu Z, Parslow TG, Olson JL, Daikh D, Killeen N, Weiss A. An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity. Cell. 2000 Dec 22; 103(7):1059-70. PMID: 11163182.
      View in: PubMed
    28. Daikh D, Wofsy D. Effects of anti-B7 monoclonal antibodies on humoral immune responses. J Autoimmun. 1999 Mar; 12(2):101-8. PMID: 10047430.
      View in: PubMed
    29. Daikh D, Wofsy D. On the horizon: clinical trials of new immunosuppressive strategies for autoimmune diseases. Transplant Proc. 1998 Dec; 30(8):4027-8. PMID: 9865285.
      View in: PubMed
    30. Wofsy D, Daikh D. Opportunities for future biological therapy in SLE. Baillieres Clin Rheumatol. 1998 Aug; 12(3):529-41. PMID: 9890111.
      View in: PubMed
    31. Daikh D, Finck BK, Linsley PS, Hollenbaugh D, Wofsy D. Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/gp39 costimulation pathways. J Immunol. 1997 Oct 1; 159(7):3104-8. PMID: 9317105.
      View in: PubMed
    32. Daikh D, Wofsy D, Imboden JB. The CD28-B7 costimulatory pathway and its role in autoimmune disease. J Leukoc Biol. 1997 Aug; 62(2):156-62. PMID: 9261329.
      View in: PubMed
    33. Neuwelt CM, Daikh D, Linfoot JA, Pfister DA, Young RG, Webb RL, London SS, Asherson RA. Catastrophic antiphospholipid syndrome: response to repeated plasmapheresis over three years. Arthritis Rheum. 1997 Aug; 40(8):1534-9. PMID: 9259436.
      View in: PubMed
    34. Daikh D, Douglass JO, Adelman JP. Structure and expression of the human motilin gene. DNA. 1989 Oct; 8(8):615-21. PMID: 2574660.
      View in: PubMed
    35. Hatfield JM, Daikh D, Adelman JP, Douglass J, Bond CT, Allen RG. In situ hybridization detection of marked differences in pre-proopiomelanocortin messenger ribonucleic acid content of individual corticotropes and melanotropes. Endocrinology. 1989 Mar; 124(3):1359-64. PMID: 2537180.
      View in: PubMed
    36. Nilaver G, Beinfeld MC, Bond CT, Daikh D, Godfrey B, Adelman JP. Heterogeneity of motilin immunoreactivity in mammalian tissue. Synapse. 1988; 2(3):266-75. PMID: 3212673.
      View in: PubMed
    David's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP